Patents by Inventor Diana Frechilla Manso

Diana Frechilla Manso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diaza- or Thiazadione Derivatives With Neuroprotective Activity
    Publication number: 20080200470
    Abstract: The present invention relates to certain derivatives of cycloalkanediones invariably substituted with a chroman-2-yl, 2-quinolyl or —O-phenyl residue which are serotonin (5-hydroxytryptamine, 5-HT) 5-HT1A receptor subtype agonists modulators, to their stereochemical isomers and to their use in the preparation of a medicament for the treatment of pathological states for which an agonist a modulator of these receptors is indicated.
    Type: Application
    Filed: January 28, 2005
    Publication date: August 21, 2008
    Inventors: Maria Luz Lopez-Rodriguez, Bellinda Benhamu Salama, Joaquin Del Rio Zambrana, Diana Frechilla Manso
  • Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications
    Patent number: 7351732
    Abstract: New cycloalkanedione derivatives that are serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists and, consequently, they are useful in the treatment of pathological states for which an agonist of these receptors is indicated. They are particularly useful as neuroprotective agents, of special interest in the treatment and prophylaxis of cerebral damage produced by traumatic or ischemic stroke.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: April 1, 2008
    Assignee: Schwarz Pharma S.L.
    Inventors: Joaquin Del Río Zambrana, Diana Frechilla Manso, M. Luz López Rodríguez, Bellinda Benhamú Salama, José Ángel Fuentes Cubero, Mercedes Delgado Wallace
  • Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
    Publication number: 20050250777
    Abstract: New cycloalkanedione derivatives that are serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists and, consequently, they are useful in the treatment of pathological states for which an agonist of these receptors is indicated. They are particularly useful as neuroprotective agents, of special interest in the treatment and prophylaxis of cerebral damage produced by traumatic or ischemic stroke.
    Type: Application
    Filed: July 29, 2003
    Publication date: November 10, 2005
    Inventors: Joaquin Del Rio Zambrana, Diana Frechilla Manso, M. Luz Lopez Rodriguez, Bellinda Benhamu Salama, Jose Angel Fuentes Cubero, Mercedes Delgado Wallace